(Total Views: 117)
Posted On: 05/03/2023 12:10:49 PM
Post# of 74576
$PRPH News Article - ProPhase Labs' Linebacker-1 Cancer Therapeutic shows promising mechanisms of action as both a mono-therapy and co-therapy in preclinical studies attacking a range of hard-to-treat cancers, including lung and gastric cancers https://marketwirenews.com/news-releases/prop...13616.html
(0)
(0)
My Twitter: WhyteStocks
